Enhancing Post-Market Evidence Generation for Medical Products

The Reagan-Udall Foundation for the FDA’s Enhancing Post-Market Evidence Generation for Medical Products report addresses barriers, proposes solutions, and makes recommendations to the FDA and other stakeholders that aim to facilitate evidence generation in the post-market setting.